These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24241085)

  • 21. Assessment of genomic instability in normal and diabetic rats treated with metformin.
    Attia SM; Helal GK; Alhaider AA
    Chem Biol Interact; 2009 Jul; 180(2):296-304. PubMed ID: 19497428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of AMP-activated protein kinase by metformin protects human coronary artery endothelial cells against diabetic lipoapoptosis.
    Eriksson L; Nyström T
    Cardiovasc Diabetol; 2014 Nov; 13():152. PubMed ID: 25391818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients.
    Chakraborty A; Chowdhury S; Bhattacharyya M
    Diabetes Res Clin Pract; 2011 Jul; 93(1):56-62. PubMed ID: 21146883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
    Rösen P; Wiernsperger NF
    Diabetes Metab Res Rev; 2006; 22(4):323-30. PubMed ID: 16444763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of metformin on the expression of tumor necrosis factor-α, Toll like receptors 2/4 and C reactive protein in obese type-2 diabetic patients].
    Andrews M; Soto N; Arredondo M
    Rev Med Chil; 2012 Nov; 140(11):1377-82. PubMed ID: 23677182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of glucose-6-phosphatase gene expression by insulin and metformin.
    Mues C; Zhou J; Manolopoulos KN; Korsten P; Schmoll D; Klotz LO; Bornstein SR; Klein HH; Barthel A
    Horm Metab Res; 2009 Oct; 41(10):730-5. PubMed ID: 19579180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
    Tawfik MK
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of activation of 5'-adenosine monophosphate-activated protein kinase in gastric ulcer healing in diabetic rats.
    Baraka AM; Deif MM
    Pharmacology; 2011; 88(5-6):275-83. PubMed ID: 22068032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
    Guppy A; Jamal-Hanjani M; Pickering L
    Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
    Matafome P; Louro T; Rodrigues L; Crisóstomo J; Nunes E; Amaral C; Monteiro P; Cipriano A; Seiça R
    Diabetes Metab Res Rev; 2011 Jan; 27(1):54-62. PubMed ID: 21218508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroprotective effects of the insulin sensitizers rosiglitazone and metformin against indomethacin-induced gastric ulcers in Type 2 diabetic rats.
    Morsy MA; Ashour OM; Fouad AA; Abdel-Gaber SA
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):173-7. PubMed ID: 19566821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
    Liu Z; Li J; Zeng Z; Liu M; Wang M
    Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YM440, a novel hypoglycemic agent, protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction.
    Nakano R; Kurosaki E; Shimaya A; Kajikawa S; Shibasaki M
    Eur J Pharmacol; 2006 Nov; 549(1-3):185-91. PubMed ID: 16989806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 Diabetes and Metformin Influence on Fracture Healing in an Experimental Rat Model.
    La Fontaine J; Chen C; Hunt N; Jude E; Lavery L
    J Foot Ankle Surg; 2016; 55(5):955-60. PubMed ID: 27286924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.